Macquarie Healthcare Fund MLTX Holdings History
Number of Shares
70,000.00
Current Holdings Value*
$2.73 Mil
% of Portfolio
0.39%
Total Estimate Gain
$885,500.00
% of Total Estimate Gain
29.36%
Macquarie Healthcare Fund's MoonLake Immunotherapeutics Holding Summary
As of 2025-03-31, Macquarie Healthcare Fund held 70,000.00 shares of MoonLake Immunotherapeutics(MLTX), totaling $2.73 Mil. This investment constitutes 0.39% of their stock portfolio, and Macquarie Healthcare Fund now holds 0.11% of the outstanding MoonLake Immunotherapeutics(MLTX) stock.
The initial trade took place in 2025Q1. And since then Macquarie Healthcare Fund has made 1 purchases of MLTX, at an average price of $43.09, for a total of 70,000.00 shares. Based on historical transaction data and MLTX's current price of $55.74, Macquarie Healthcare Fund's estimated gain on his MLTX holdings is $885,500.00, reflecting a 29.36% gain to date.
Macquarie Healthcare Fund MLTX ($55.74) Holding Chart
Macquarie Healthcare Fund MLTX ($55.74) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1